View Press Releases
-
Oxford Medical Products raises £2.5 million for its hydrogel weight-loss platform technology
Oxford Medical Products has raised £2.5M in equity investment to conduct first human trials of Sirona, its innovative non-surgical weight-loss solution. Sirona is a hydrogel-based technology in a tablet format that, once swallowed, expands in the stomach, stops feelings of hunger and suppresses appetite.
Mar 8, 2022
-
Aragen acquires Intox Pvt. Ltd
-
Watson-Marlow Fluid Technology Group drives growth with new Operations and Supply Director
Abdul Butt joins Watson-Marlow Fluid Technology Group as Operations and Supply Director to drive the company’s supply excellence and enable continued growth. Abdul joins the company with extensive experience in Manufacturing and Operational Excellence, including 20 years at GKN PLC and then Melrose Industries as CEO of one of their divisions, followed by MPP where he was Chief Operating Officer in his most recent role.
Mar 9, 2022
-
NanoSyrinx appoints R&D industry leader Dr Marie McAvoy as Chief Scientific Officer
NanoSyrinx has strengthened its management team with the appointment of Dr Marie McAvoy as its Chief Scientific Officer.
Mar 9, 2022
-
Senior Biopharma Executive Joins MMS Holdings as Principal Medical Director
MMS Holdings, a data-focused contract research organization (CRO), announced the addition of Robert Allen, MD, to its team as Principal Medical Director of Global Drug Safety and Pharmacovigilance.
Mar 9, 2022
-
Vyasa Introduces Cortex: Intuitive, Visual Data Fabric Creation & Management
Vyasa, an innovative provider of highly scalable deep learning A.I. analytics software for healthcare, life sciences and business applications, today debuts its latest application, Cortex. An intuitive data management tool, Cortex acts as the “blueprint” of the data fabric by allowing users to build, manage and provision access to data sources connected to Vyasa Layar data fabrics.
Mar 9, 2022
-
Emmes Acquires Casimir, Its Fourth Major Acquisition
-
Japan tops CPhI ‘API Quality’ ranking for second year
-
Alfa Chemistry—A Supplier of Active Pharmaceutical Ingredients
-
Emmes Supports New Collaboration to Accelerate COVID-19 Research for Children
-
mdgroup Listed Among the UK’s Fastest-Scaling Firms in Organic Growth 25 Index
Bracknell, UK – 14th February 2022: mdgroup, a leading global medtech and patient health services company pioneering a patient-first approach to clinical research, has been named as one of the UK's fastest-scaling businesses in 2021's Organic Growth 25 (OG25) index in recognition of its major growth and success, without significant external investment.
Feb 13, 2022
-
mdgroup Appoints Steph Katz as Director of Seacole Health
mdgroup Appoints Steph Katz as Director of Seacole Health Combining Passion for Nursing and Clinical Research to Provide Remarkable Patient Experiences Bracknell, UK: 15 February 2022 - mdgroup, the leading global provider of personalised clinical study services, has appointed Steph Katz as Director of business subsidiary Seacole Health. Seacole Health brings mdgroup’s mobile health and clinical research staff resourcing under one roof. Steph is the ideal person to lead this exciting new venture because of her wealth of healthcare knowledge. Having started as an oncology nurse in intensive care units, Steph achieved her MSN in Nursing Education and began training research coordinators, clinical nurses and fellows. She then took on a management role, helping to develop and operationalize institutional, federal and commercial clinical research projects before pursuing an MBA.
Feb 14, 2022
-
PubHive Unveils New Dashboard for Systematic Review SaaS Solution
AI-powered cloud software platform PubHive Navigator now features a new user dashboard that speeds up systematic literature review workflows for PubHive users
Feb 15, 2022
-
Curebase Adds Two Clinical Trial Veterans to Kick-off New Advisory Board
Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board.
Feb 15, 2022
-
Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures
Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures
Feb 15, 2022
-
New PROFINET-enabled pumps from Watson-Marlow enable seamless integration of fluid delivery up to enterprise-level
Watson-Marlow Fluid Technology Group (WMFTG) is extending its industrial Ethernet control offer by making PROFINET available on its 530, 630 and 730 series of cased peristaltic pumps. This additional communication capability allows customers to access fast, accurate performance data and seamless connectivity with modern PLC control systems and the Internet of Things (IoT) using either EtherNet/IP™ or PROFINET®.
Feb 15, 2022
-
University of Miami Medical Researchers Accelerate Future of Personalized Wellness with the MILBox Project
Researchers at the University of Miami have unveiled a groundbreaking research project called the MILBox, which uses AI to create “digital twins” of patients. Once created, healthcare practitioners can test and evaluate various treatment options and potential outcomes on these “digital twins,” before applying them in the physical world. The study is supported by Amazon Web Services and Open Health Network, which use data from wearables and in-home sensors to create these “digital twins."
Feb 15, 2022
-
QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL PHARMACEUTICS® PLATFORM
-
MetaboParis-Santé platform first in France to install Bruker In Vitro Diagnostic research by NMR* system at Université de Paris
Université de Paris has installed new Bruker In Vitro Diagnostic research (IVDr) nuclear magnetic resonance (NMR) spectrometer within its MetaboParis-Santé platform located in the center of Paris city, France.
Jan 25, 2022
-
Parkinson’s UK and Domainex collaborate to develop therapies targeting neuroinflammation to slow the progression of Parkinson’s
Parkinson’s UK, the largest charitable funder of Parkinson’s research in Europe, and Domainex Ltd., today announce a collaboration focused on developing small molecule therapies targeting neuroinflammation that could slow the progression of Parkinson’s.
Feb 2, 2022